Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

Oncotarget | Mitochondria Engage the Integrated Stress Response to Promote Tumor Growth

News

March 8, 2023
PRESS RELEASE: On February 25, 2023, researchers from the University of Colorado published a new editorial in Oncotarget, entitled, “Mitochondria engage the integrated stress response to promote tumor growth.” continue reading »

Oncotarget | HALP Score: Prognostic Ability in Cancers – A Literature Review

News

March 6, 2023
PRESS RELEASE: On February 25, 2023, Oncotarget published a new review, entitled, “What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types.” continue reading »

Oncotarget | Unveiling the Non-canonical Functions of EZH2 in Prostate Cancer

News

March 3, 2023
PRESS RELEASE: On February 11, 2023, researchers from Northwestern University published a new editorial in Oncotarget, entitled, “Unveiling the non-canonical functions of EZH2 in prostate cancer.” continue reading »

Oncotarget | WNT-pathway Medulloblastoma: What Constitutes Low-risk and How Low Can One Go?

News

February 27, 2023
PRESS RELEASE: On February 7, 2023, a new research perspective was published in Oncotarget, entitled, “WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?” continue reading »